financetom
Business
financetom
/
Business
/
EXCLUSIVE: CleanCore Seals $2.48 Million Sanzonate Deal With $1.25 Million Earnout, Unlocks $20 Million Sales Pipeline in Europe
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EXCLUSIVE: CleanCore Seals $2.48 Million Sanzonate Deal With $1.25 Million Earnout, Unlocks $20 Million Sales Pipeline in Europe
Feb 25, 2025 6:01 AM

On Tuesday, CleanCore Solutions, Inc ( ZONE ) announced it has executed a definitive agreement to acquire Sanzonate Europe Ltd, a distributor of aqueous ozone cleaning technologies in Europe.

CleanCore has secured the deal primarily through a seller-financed carryback note and an earnout, minimizing upfront costs and aligning incentives for future growth.

The financing terms include a cash payment of $600,000, a $625,000 promissory note, due in two years at 10% interest, and annual earnout payments for 5 years totaling up to $1,250,000 (approximately 10% payment for every $2 million in sales).

Also Read: Disney Appoints Former Paramount Exec Daria Cercek to Lead Live-Action Films, Reshaping Studio Leadership

CleanCore expects to gain approximately $500,000 in inventory and $450,000 in accounts receivable as part of the acquisition.

The company believes this strategic acquisition will deliver immediate accretion, drive higher-margin revenue growth, and unlock a substantial multi-million-dollar sales pipeline.

Sanzonate currently has over 30 distribution partners and direct customers and a net backlog of over $10 million. The acquisition will unlock a sales pipeline of approximately $20+ million, providing future visibility into top-line growth.

The transaction will likely eliminate intermediaries, improving gross margins and EBITDA.

CleanCore will not assume any liabilities, ensuring a clean balance sheet post-transaction. CleanCore expects to gain complete control of Europe’s largest aqueous ozone distribution network.

The company believes that acquiring the Sanzonate infrastructure and personnel will position CleanCore for rapid scalability across Asia, South America, and other key international markets.

CleanCore believes the proposed acquisition will align with Europe’s focus on green cleaning solutions.

With the full integration of Sanzonate’s established distribution network, a seasoned EU-based leadership team, and an untapped backlog of demand, CleanCore will likely solidify its position as the global leader in sustainable cleaning solutions.

The company believes the acquisition will give it direct control over Europe’s largest aqueous ozone distribution network, allowing it to capitalize on Europe’s accelerating corporate sustainability and green initiatives.

The acquisition’s completion is subject to several conditions. It will likely close by March 7, 2025.

CleanCore Solutions ( ZONE ) held $0.56 million in cash and equivalents as of December 31, 2024.

Price Action: ZONE stock closed lower by 0.93% at $1.07 Monday.

Read Next:

Alibaba’s AI Expansion, E-Commerce Growth Reinforce Bullish Analyst Outlook

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BMO on The Day Ahead in Canada
BMO on The Day Ahead in Canada
Dec 13, 2024
07:33 AM EST, 12/13/2024 (MT Newswires) -- Canada will release Q3 capacity utilization at 8:30 a.m. ET Friday, noted Bank of Montreal (BMO)- The bank said Q3 capacity utilization is expected to edge down to 78.5% after climbing to 79.1% in the prior quarter. Overall, capacity utilization has held just under 80% for much of the past four years. Meantime,...
Geron's Rytelo Secures European Medicines Agency Committee's Approval Recommendation
Geron's Rytelo Secures European Medicines Agency Committee's Approval Recommendation
Dec 13, 2024
07:30 AM EST, 12/13/2024 (MT Newswires) -- Geron ( GERN ) said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of Rytelo for the treatment of adult patients with transfusion-dependent anemia due to lower risk myelodysplastic syndromes. The company said the committee considered the data from a phase 3 clinical trial,...
Guardian Capital Group Renews Share Buyback
Guardian Capital Group Renews Share Buyback
Dec 13, 2024
07:36 AM EST, 12/13/2024 (MT Newswires) -- Guardian Capital Group ( GRCGF ) on Friday said the Toronto Stock Exchange approved its buyback of up to 136,918 of common shares and up to 1.5 million non-voting class A shares. The normal course issuer bid (NCIB) will run from Dec. 19 for one year. Under its current NCIB, which expires on...
Surge Copper Secures Option to Buy MacLean East Property Near Berg Project in British Columbia
Surge Copper Secures Option to Buy MacLean East Property Near Berg Project in British Columbia
Dec 13, 2024
07:35 AM EST, 12/13/2024 (MT Newswires) -- Surge Copper ( SRGXF ) said Friday that it secured an option to acquire the MacLean East property located near the Berg project in British Columbia. Surge will allocate $300,000 in assessment work credits to MacLean East Property and other contiguous mineral claims owned by the vendors within 30 days. Surge will also...
Copyright 2023-2026 - www.financetom.com All Rights Reserved